Simplified treatment for H. pylori guided by a stool test
Treatments studied
Part of Digestive system, Infections clinical trials.
This trial tests a simpler two-drug treatment for H. pylori infection, chosen based on a stool test that checks if the bacteria are resistant to clarithromycin. It may help people who have not been treated before avoid unnecessary antibiotics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have an active H. pylori infection confirmed by both a breath test and a stool test.
- You have never been treated for H. pylori before.
- You are not pregnant or breastfeeding.
- You haven't taken certain stomach acid medicines (like PPIs) in the past 2 weeks, or antibiotics or bismuth in the past 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different antibiotic treatment plans for H. pylori, a common stomach bacteria that causes ulcers and digestive problems. The trial tests whether a higher dose of one medication (vonoprazan) works better than a different antibiotic combination.
This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.
This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.
This study tests if analyzing a stool sample can help choose the right antibiotics to clear a stubborn H. pylori infection that hasn't been cured before. It aims to improve treatment success with fewer side effects.
This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.
This trial studies how to eradicate Helicobacter pylori (a germ in the stomach) and monitor follow-up results after treatment. You may be a candidate if you have confirmed infection and have not taken certain stomach medicines or antibiotics recently.
Hear when a new Helicobacter Pylori Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.